Literature DB >> 16278598

Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome.

Nina Singh1, Olivier Lortholary, Barbara D Alexander, Krishan L Gupta, George T John, Kenneth Pursell, Patricia Munoz, Goran B Klintmalm, Valentina Stosor, Ramon delBusto, Ajit P Limaye, Jyoti Somani, Marshall Lyon, Sally Houston, Andrew A House, Timothy L Pruett, Susan Orloff, Atul Humar, Lorraine Dowdy, Julia Garcia-Diaz, Robert A Fisher, Shahid Husain.   

Abstract

This study describes the association of allograft loss and immune reconstitution syndrome (IRS) in the course of Cryptococcosis neoformans infection in renal transplant recipients. Patients comprised 54 renal allograft recipients with cryptococcosis in a prospective, multicenter study. IRS developed in 5.5% (3/54) of the renal transplant recipient with C. neoformans infection. The renal allograft was lost to chronic rejection in 66% (2/3) of the patients with cryptococcosis who developed IRS compared to 5.9% (3/51) of those who did not (P=0.012). Kaplan-Meier survival analysis showed that subsequent to cryptococcal infection the probability of allograft survival was significantly lower in patients who developed IRS compared to those who did not develop IRS (P=0.0004). Temporal association of graft loss with IRS suggests a common pathophysiologic basis for these entities with implications relevant for the optimal management of renal transplant recipients with cryptococcosis.

Entities:  

Mesh:

Year:  2005        PMID: 16278598     DOI: 10.1097/01.tp.0000180530.17683.02

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  Peer reviewed publications in 2005.

Authors: 
Journal:  Ochsner J       Date:  2006

Review 3.  Cryptococcosis.

Authors:  Eileen K Maziarz; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

4.  Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans.

Authors:  Scott R Waterman; Moshe Hacham; Guowu Hu; Xudong Zhu; Yoon-Dong Park; Soowan Shin; John Panepinto; Tibor Valyi-Nagy; Craig Beam; Shahid Husain; Nina Singh; Peter R Williamson
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

Review 5.  Cryptococcosis in solid organ transplant recipients: current state of the science.

Authors:  Nina Singh; Francoise Dromer; John R Perfect; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

6.  Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Authors:  Hsin-Yun Sun; Barbara D Alexander; Shirish Huprikar; Graeme N Forrest; Didier Bruno; G Marshall Lyon; Dannah Wray; Leonard B Johnson; Costi D Sifri; Raymund R Razonable; Michele I Morris; Valentina Stosor; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2014-09-09       Impact factor: 9.079

7.  Neurological complications of solid organ transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-07

Review 8.  Invasive fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham; Kieren A Marr
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

Review 9.  New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.

Authors:  Elvis Temfack; Timothée Boyer-Chammard; David Lawrence; Sarah Delliere; Angela Loyse; Fanny Lanternier; Alexandre Alanio; Olivier Lortholary
Journal:  Curr Neurol Neurosci Rep       Date:  2019-10-31       Impact factor: 5.081

10.  Isolated cavitary lung disease in a renal allograft recipient: A rare manifestation of cryptococcus.

Authors:  J S Sandhu; V Makkar; P M Sohal; A Singh; H Kaur; J Sandhu
Journal:  Indian J Nephrol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.